Q-linea
Company Details
Status: Private
Employees: 51-100
Location:
Dag Hammarskjölds väg 52 A, Uppsala, Uppsala 752 37, SE
Type:
sample
sample
sample
Technology:
sample
sample
About: Q-linea AB is a Swedish medical technology company based in Uppsala, founded in 2007. The company focuses on developing innovative solutions for infection diagnostics, aiming to enhance the diagnosis and treatment of infectious diseases, particularly sepsis. Q-linea's mission is to provide rapid and accurate diagnostic tools that benefit patients and healthcare providers.
The company specializes in in-vitro diagnostic systems, with its key product being ASTar, an antibiotic susceptibility testing system for positive blood cultures. This system aids healthcare providers in diagnosing and treating infections by delivering critical information on antibiotic resistance, thereby helping to reduce antibiotic misuse. Q-linea employs a targeted commercial strategy in key European markets, including the UK, Italy, and Benelux, and has established partnerships to expand its reach.
Under the leadership of CEO Stuart Gander, Q-linea has made significant strides in its growth and product development. In 2023, the company raised approximately SEK 263 million through a rights issue to support its strategic initiatives and achieved IVDR certification for its diagnostic products.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Q-linea | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.